BioLife Solutions, Inc. (BLFS) Return on equity 2018–2025
BioLife Solutions, Inc. (BLFS) return on equity by fiscal year — reported net income divided by year-end shareholders’ equity.
-1.2%FY2025 · since FY2018: -170.9% → -1.2%
| Fiscal year | Value | YoY |
|---|---|---|
| FY2025 | -1.2% | +4.5 pp |
| FY2024 | -5.8% | +14.4 pp |
| FY2023 | -20.1% | +18.2 pp |
| FY2022 | -38.4% | -36.5 pp |
| FY2021 | -1.9% | -2.8 pp |
| FY2020 | 1.0% | +4.8 pp |
| FY2019 | -3.8% | +167.1 pp |
| FY2018 | -170.9% | — |
ROE = reported net income ÷ reported year-end shareholders’ equity for the same fiscal year. Heavy buybacks shrink equity and can push ROE very high (or negative-equity years drop out).
Source: SEC XBRL filings · For reference only · Not investment advice
More BLFS financial trends
BLFS RevenueBLFS Net incomeBLFS Net marginBLFS Gross profitBLFS Gross marginBLFS Operating incomeBLFS Operating marginBLFS Operating cash flowBLFS Free cash flowBLFS Capital expendituresBLFS Stock buybacksBLFS Dividends paidBLFS Total assetsBLFS Total liabilitiesBLFS Shareholders’ equityBLFS overview →